Taming killer cells may halt diabetes progression
Research output: Contribution to journal › Debate/Note/Editorial
Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell-mediated recognition of pancreatic beta cells.
|Research areas and keywords||
Subject classification (UKÄ) – MANDATORY